Indian Journal of Surgery

, Volume 73, Issue 1, pp 9–12 | Cite as

Hormone Receptor Status of Breast Cancer in the Himalayan Region of Northern India

  • Rashmi KaulEmail author
  • Jaishree Sharma
  • Satinder S. Minhas
  • Kavita Mardi
Original Article


The role of hormone receptors as a prognostic and therapeutic tool in breast cancer is widely accepted. The frequency of nonreactivity of estrogen and progesterone receptors in breast cancer patients of India is much more common than in the West. This study was conducted with the aim of analysis of steroid receptor status in breast cancer with clinico-pathological characteristics from the northern hilly state of Himachal Pradesh, India located in the region of the Western Himalayas. Fifty five consecutive patients with the diagnosis of breast cancer were included in this study. Detailed clinical and histopathologic data was recorded in all cases. Estrogen receptor and progesterone receptor status was evaluated by immunohistochemistry. Chi-square test was used for statistical analysis. On immunohistochemical staining, 34.5% cases proved to be estrogen receptor positive and 36.4% cases progesterone receptor positive. The results in the present study documented low estrogen receptor and progesterone receptor positivity in breast cancer from this region of India.


Breast cancer Steroid receptor Western Himalayas 


  1. 1.
    Desai SB, Moonim MT, Gill AK, Punia RS, Naresh KN, Chinoy RF (2000) Hormone receptor status of breast cancer in India: a study of 798 tumors. Breast 9:267–270PubMedCrossRefGoogle Scholar
  2. 2.
    Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9:R6PubMedCrossRefGoogle Scholar
  3. 3.
    Mandal AK (1995) Hormone receptors in breast carcinoma. Indian J Pathol Microbiol 38:109–118PubMedGoogle Scholar
  4. 4.
    Leake R (2000) Comment. Breast 9:270Google Scholar
  5. 5.
    Raina V, Bhutani M, Bedi R, Sharma A, Deo SVS, Shukla NK (2005) Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer 42:40–45PubMedCrossRefGoogle Scholar
  6. 6.
    Raina V, Taneja V, Gulati A, Deo SVS, Shukla NK, Vij U (2000) Oestrogen receptor status in breast cancer. Indian Pract 53:405–407Google Scholar
  7. 7.
    Redkar AA, Kabre SS, Mittra I (1992) Estrogen and progesterone receptors measurement in breast cancer with enzyme-immunoassay and correlation with other prognostic factors. Indian J Med Res 96:1–8PubMedGoogle Scholar
  8. 8.
    Dutta V, Chopra GS, Sahai K, Nema SK (2008) Hormone receptors, Her-2/Neu and chromosomal aberrations in breast cancer. MJAFI 64:11–15Google Scholar
  9. 9.
    Kumar V, Tewari M, Singh U, Shukla HS (2007) Significance of Her-2/neu protein over expression in Indian breast cancer patients. Indian J Surg 69:122–128CrossRefGoogle Scholar
  10. 10.
    Fisher ER, Redmond CK, Liu H (1980) Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer. Cancer 45:349PubMedCrossRefGoogle Scholar

Copyright information

© Association of Surgeons of India 2010

Authors and Affiliations

  • Rashmi Kaul
    • 1
    Email author
  • Jaishree Sharma
    • 1
  • Satinder S. Minhas
    • 1
  • Kavita Mardi
    • 1
  1. 1.Indira Gandhi Medical CollegeShimlaIndia

Personalised recommendations